Vertical transmission of human immunodeficiency virus type 1 in Japan,1989–1997: Presence of two subtypes B and E with subtype E predominance

Pediatrics International

Volumn 40, Issue 5, 1998, Pages 503-509

  Yoshino, Naoto ^a,b,c   Naganawa, Satoshi ^b   Nakasone, Tadashi ^a,b   Imura, Soichi ^a,d   Kita, Tsunekazu ^a,e   Honda, Mitsuo ^a,b  

^a National Cooperative Study Group on Vertical Transmission of HI V 1   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^e NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Clade E virus; Human immunodeficiency virus type 1; Japan; Vertical transmission

Indexed keywords

ZIDOVUDINE;

ADULT; CONTROLLED STUDY; DNA SEQUENCE; ETHNOLOGY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFANT; JAPAN; MOTHER FETUS RELATIONSHIP; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; VIRUS ISOLATION; VIRUS TRANSMISSION;

CONSENSUS SEQUENCE; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL PROTEINS;

EID: 0031679911     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1998.tb01980.x     Document Type: Article

References (23)

1. Saag Ms, Hahn Bh, Givons J. et al. Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 1988; 334: 440–4.
2. European Collaborative Study. Children born to women with HIV-1 infection: Natural history and risk of transmission. Lancet 1991;337: 253–60.
3. Peckham C., Gibb D. Mother to child transmission of the human immunodeficiency virus. N. Engl. J. Med. 1995; 333: 298–302.
4. Ehrnst A. Lindgen S., Dictor M. HIV in pregnant women and their offspring: Evidence of late transmission. Lancet 1991; 338: 203–7.
5. Halsey Na, Boulos R., Holt E. Transmission of HIV-1 infections from mothers to infants in Haiti. Impact on childhood mortality and malnutrition. The CDS/IHU AIDS Project Team. JAMA 1990; 264: 2088–92.
6. World Health Organization. Global programme on AIDS: Consensus statement from WHO/UNICEF consultation on HIV transmission and breast feeding. Wkly Epidemiol. Rec. 1992; 67: 177–9.
7. Scarlatti G. Pediatric HIV infection. Lancet 1996; 348: 863–8.
8. Bryson Yj. Perinatal HIV-1 transmission: Recent advances and therapeutic interventions. AIDS 1996; 10 (Suppl. 3): S33–S42.
9. European Collaborative Study. Natural history of vertically acquired HIV-I infection. Pediatrics 1994; 94: 815–19.
10. Centers for Disease Control and Prevention. Recommendation of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994; 43 (RR-11): 1–20.
11. Yamanaka T., Fujimura Y., Ishimoto S., et al. Correlation of titer of antibody to principal neutralizing domain of HIV/MN strain with disease progression in Japanese hemophiliacs seropositive for HIV type I. AIDS Res. Hum. Retroviruses 1997; 13: 317–26.
12. Okamoto Y., Shiosaki K., Eda Y. et al. Father-to-mother-to-infant transmission of HIV-1: Clonally transmitted isolate of infant mutates more rapidly than that of the mother and rapidly loses reactivity with neutralizing antibody. Microbiol. Immunol. 1997:77: 131–8.
13. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43 (RR-12): 1–10.
14. Honda M., Matsuo K., Nakasone T., et al. Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals. Proc. Natl Acad. Sci. USA 1995; 92: 10 693–5.
15. Honda M., Kitamura K., Mizutani Y. et al. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. J. Immunol. 1990; 145: 4059–64.
16. Pau Cp. Kai M., Holloman-Candal Dl et al. Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization. AIDS Res. Hum. Retroviruses 1994; 10: 1369–77.
17. Ou Cy, Takebe Y., Weniger Bg et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 1993; 341: 1171–4.
18. National Institute of Infectious Diseases and Infectious Diseases Control Division, Ministry of Public Health. AIDS and HIV infections in Japan. IASR 1997; 18: 211–13.
19. Myers G., Korber B., Berzofsky Ja, Smith Rf, Pavlakis Gn. Human Retroviruses and AIDS. Los Alamos: Los Alamos National Laboratory.
20. Weniger Bg, Takebe Y., Ou Yc, Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS 1994; 8 (Suppl. 2): S13–28.
21. Artenstein Aw, Coppola J., Arown Ae et al. Multiple introduction of HIV-1 subtype E into the western hemisphere. Lancet 1995, 346: 1197–8.
22. Yu Xf, Wang Z., Beyrer C. et al. Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. J. Virol. 1995; 69: 4649–55.
23. Kitsutani Pt, Naganawa S., Shiino T. et al. HIV type 1 subtypes of non-hemophiliac patients in Japan. AIDS Res. Hum. Retrov. 1998; 14: (In press).